Eosinophilic Cystitis: Diagnosis and Treatment
Diagnostic Approach
Cystoscopy with bladder biopsy is mandatory to establish the diagnosis of eosinophilic cystitis, as there is no pathognomonic clinical presentation or typical endoscopic appearance. 1, 2
Clinical Presentation
The condition presents with variable symptoms depending on age:
- In children (particularly infants): Suprapubic mass and bilateral hydroureteronephrosis are common presentations 2
- In older children and adults: Urinary frequency (67%), dysuria (62%), gross or microscopic hematuria (68%), suprapubic pain (49%), and urinary retention (10%) 1
- Gender distribution: Equal between males and females overall, but boys are affected more frequently than girls in the pediatric population (14% vs 7%) 1
Diagnostic Workup
Perform the following evaluations:
- Cystoscopy with biopsy (essential and diagnostic): Look for eosinophilic infiltration of the bladder wall; endoscopic findings may include petechiae, pseudotumor lesions, or normal-appearing mucosa 1, 2, 3
- Peripheral blood eosinophil count: Present in only 43% of cases, so absence does not exclude diagnosis 1
- Urinalysis and culture: Positive cultures found in 26% of patients 1
- Upper tract imaging (ultrasound or IVU): Essential to evaluate for hydronephrosis, which occurs in 27% of cases 1, 4
- Allergy history: Document history of asthma, allergies, or other atopic conditions 1, 2
Treatment Algorithm
First-Line Medical Management
The optimal treatment is transurethral resection of bladder lesions (when pseudotumor present) combined with corticosteroids and antihistamines. 1
Specific regimen:
- Corticosteroids: Prednisone 1-2 mg/kg/day (maximum 60 mg) for 8-12 weeks 5, 4
- Antihistamines: Add as adjunctive therapy 1, 2
- Antibiotics: Only when urinary tract infection is documented or upper tract dilation exists 1
Treatment Based on Presentation
For pseudotumor lesions:
- Perform transurethral resection followed by medical therapy with corticosteroids and antihistamines 1, 3
For non-mass lesions (petechiae or normal-appearing mucosa):
For minimally symptomatic cases:
- Consider conservative management with nonsteroidal anti-inflammatory drugs and observation 3
Management of Complications
Unilateral or bilateral hydronephrosis:
- Conservative management is appropriate with medical therapy alone 4
- Reserve surgical intervention for refractory cases with persistent upper tract obstruction 1
Refractory disease despite standard therapy:
- Consider low-dose cyclosporine (immunosuppressive therapy) for cases unresponsive to corticosteroids, antihistamines, and other conventional treatments 6
- Total cystectomy is reserved only for patients with unresponsive disease and persistent severe hematuria 1
Monitoring and Follow-up
- Clinical response: Symptoms typically improve within 7 days of initiating corticosteroid therapy 5
- Histological assessment: Repeat cystoscopy with biopsy at 8-12 weeks to evaluate treatment response 5, 7
- Upper tract surveillance: Serial imaging to monitor for resolution of hydronephrosis 4
- Recurrence monitoring: Recurrence is frequent, requiring long-term follow-up even after successful initial treatment 1, 2
Critical Pitfalls to Avoid
- Do not rely on peripheral eosinophilia for diagnosis, as it is absent in 57% of cases 1
- Do not delay cystoscopy and biopsy based on clinical suspicion alone; histological confirmation is essential 1, 2
- Do not perform total cystectomy as initial treatment; reserve for truly refractory cases with severe hematuria 1
- Do not overlook upper tract evaluation, as hydronephrosis occurs in over one-quarter of patients 1, 4